Selective use of abciximab in coronary stenting: overall outcomes can still be equivalent to those in the EPISTENT treatment group

Author: Price DJA   Campbell PG   Sutton AGC   Grech ED   Davies A   Hall JA   de Belder MA  

Publisher: Informa Healthcare

ISSN: 1471-1796

Source: International Journal of Cardiovascular Interventions, Vol.4, Iss.1, 2001-03, pp. : 15-20

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content